nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—Acitretin—psoriasis	0.11	0.154	CbGbCtD
Pethidine—CYP2B6—Cholecalciferol—psoriasis	0.0608	0.0847	CbGbCtD
Pethidine—ALB—Mycophenolate mofetil—psoriasis	0.0517	0.072	CbGbCtD
Pethidine—CYP2D6—Hydroxyurea—psoriasis	0.0485	0.0675	CbGbCtD
Pethidine—ALB—Prednisone—psoriasis	0.0413	0.0575	CbGbCtD
Pethidine—CYP2C19—Cholecalciferol—psoriasis	0.0387	0.0538	CbGbCtD
Pethidine—CYP3A4—Calcitriol—psoriasis	0.0363	0.0505	CbGbCtD
Pethidine—CYP2D6—Cholecalciferol—psoriasis	0.0294	0.0409	CbGbCtD
Pethidine—CYP3A4—Methoxsalen—psoriasis	0.0282	0.0393	CbGbCtD
Pethidine—CYP2C19—Prednisone—psoriasis	0.0268	0.0373	CbGbCtD
Pethidine—CYP2B6—Dexamethasone—psoriasis	0.0263	0.0366	CbGbCtD
Pethidine—CYP2C19—Cyclosporine—psoriasis	0.0254	0.0354	CbGbCtD
Pethidine—ALB—Methotrexate—psoriasis	0.0207	0.0289	CbGbCtD
Pethidine—CYP2D6—Cyclosporine—psoriasis	0.0193	0.0269	CbGbCtD
Pethidine—CYP3A4—Cholecalciferol—psoriasis	0.0187	0.026	CbGbCtD
Pethidine—CYP2C19—Dexamethasone—psoriasis	0.0167	0.0233	CbGbCtD
Pethidine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0162	0.0226	CbGbCtD
Pethidine—CYP3A4—Triamcinolone—psoriasis	0.0162	0.0226	CbGbCtD
Pethidine—CYP3A4—Betamethasone—psoriasis	0.0139	0.0194	CbGbCtD
Pethidine—CYP3A4—Prednisolone—psoriasis	0.0137	0.0191	CbGbCtD
Pethidine—CYP3A4—Hydrocortisone—psoriasis	0.013	0.0181	CbGbCtD
Pethidine—CYP3A4—Prednisone—psoriasis	0.013	0.018	CbGbCtD
Pethidine—CYP2D6—Dexamethasone—psoriasis	0.0127	0.0177	CbGbCtD
Pethidine—CYP3A4—Cyclosporine—psoriasis	0.0123	0.0171	CbGbCtD
Pethidine—CYP3A4—Dexamethasone—psoriasis	0.00809	0.0113	CbGbCtD
Pethidine—Hallucination—Betamethasone—psoriasis	0.000354	0.00145	CcSEcCtD
Pethidine—Convulsion—Cyclosporine—psoriasis	0.000354	0.00145	CcSEcCtD
Pethidine—Asthenia—Hydroxyurea—psoriasis	0.000353	0.00144	CcSEcCtD
Pethidine—Hypertension—Cyclosporine—psoriasis	0.000352	0.00144	CcSEcCtD
Pethidine—Constipation—Mycophenolic acid—psoriasis	0.000352	0.00144	CcSEcCtD
Pethidine—Palpitations—Mycophenolate mofetil—psoriasis	0.000352	0.00144	CcSEcCtD
Pethidine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.00035	0.00143	CcSEcCtD
Pethidine—Anxiety—Cyclosporine—psoriasis	0.000346	0.00142	CcSEcCtD
Pethidine—Convulsion—Mycophenolate mofetil—psoriasis	0.000345	0.00141	CcSEcCtD
Pethidine—Hypertension—Mycophenolate mofetil—psoriasis	0.000344	0.00141	CcSEcCtD
Pethidine—Visual impairment—Dexamethasone—psoriasis	0.000343	0.0014	CcSEcCtD
Pethidine—Visual impairment—Betamethasone—psoriasis	0.000343	0.0014	CcSEcCtD
Pethidine—Erythema—Triamcinolone—psoriasis	0.000342	0.0014	CcSEcCtD
Pethidine—Dry mouth—Cyclosporine—psoriasis	0.00034	0.00139	CcSEcCtD
Pethidine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000339	0.00139	CcSEcCtD
Pethidine—Anxiety—Mycophenolate mofetil—psoriasis	0.000338	0.00138	CcSEcCtD
Pethidine—Confusional state—Cyclosporine—psoriasis	0.000336	0.00137	CcSEcCtD
Pethidine—Vertigo—Prednisolone—psoriasis	0.000334	0.00136	CcSEcCtD
Pethidine—Anaphylactic shock—Cyclosporine—psoriasis	0.000333	0.00136	CcSEcCtD
Pethidine—Oedema—Cyclosporine—psoriasis	0.000333	0.00136	CcSEcCtD
Pethidine—Syncope—Prednisolone—psoriasis	0.000333	0.00136	CcSEcCtD
Pethidine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000332	0.00136	CcSEcCtD
Pethidine—Confusional state—Mycophenolate mofetil—psoriasis	0.000328	0.00134	CcSEcCtD
Pethidine—Loss of consciousness—Prednisolone—psoriasis	0.000326	0.00133	CcSEcCtD
Pethidine—Vertigo—Hydrocortisone—psoriasis	0.000326	0.00133	CcSEcCtD
Pethidine—Syncope—Hydrocortisone—psoriasis	0.000325	0.00133	CcSEcCtD
Pethidine—Dizziness—Hydroxyurea—psoriasis	0.000325	0.00133	CcSEcCtD
Pethidine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000325	0.00133	CcSEcCtD
Pethidine—Oedema—Mycophenolate mofetil—psoriasis	0.000325	0.00133	CcSEcCtD
Pethidine—Hyperhidrosis—Cyclosporine—psoriasis	0.000322	0.00132	CcSEcCtD
Pethidine—Convulsion—Prednisolone—psoriasis	0.000322	0.00132	CcSEcCtD
Pethidine—Hypertension—Prednisolone—psoriasis	0.000321	0.00131	CcSEcCtD
Pethidine—Shock—Mycophenolate mofetil—psoriasis	0.00032	0.00131	CcSEcCtD
Pethidine—Loss of consciousness—Hydrocortisone—psoriasis	0.000319	0.0013	CcSEcCtD
Pethidine—Anorexia—Cyclosporine—psoriasis	0.000318	0.0013	CcSEcCtD
Pethidine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000317	0.0013	CcSEcCtD
Pethidine—Bradycardia—Prednisone—psoriasis	0.000316	0.00129	CcSEcCtD
Pethidine—Convulsion—Hydrocortisone—psoriasis	0.000314	0.00128	CcSEcCtD
Pethidine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000314	0.00128	CcSEcCtD
Pethidine—Hypertension—Hydrocortisone—psoriasis	0.000313	0.00128	CcSEcCtD
Pethidine—Vomiting—Hydroxyurea—psoriasis	0.000313	0.00128	CcSEcCtD
Pethidine—Rash—Hydroxyurea—psoriasis	0.00031	0.00127	CcSEcCtD
Pethidine—Erythema—Dexamethasone—psoriasis	0.00031	0.00127	CcSEcCtD
Pethidine—Erythema—Betamethasone—psoriasis	0.00031	0.00127	CcSEcCtD
Pethidine—Anorexia—Mycophenolate mofetil—psoriasis	0.00031	0.00127	CcSEcCtD
Pethidine—Dermatitis—Hydroxyurea—psoriasis	0.00031	0.00127	CcSEcCtD
Pethidine—Hallucination—Prednisone—psoriasis	0.000308	0.00126	CcSEcCtD
Pethidine—Headache—Hydroxyurea—psoriasis	0.000308	0.00126	CcSEcCtD
Pethidine—Anxiety—Hydrocortisone—psoriasis	0.000308	0.00126	CcSEcCtD
Pethidine—Vertigo—Triamcinolone—psoriasis	0.000307	0.00125	CcSEcCtD
Pethidine—Syncope—Triamcinolone—psoriasis	0.000306	0.00125	CcSEcCtD
Pethidine—Hypotension—Mycophenolate mofetil—psoriasis	0.000304	0.00124	CcSEcCtD
Pethidine—Oedema—Prednisolone—psoriasis	0.000303	0.00124	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisolone—psoriasis	0.000303	0.00124	CcSEcCtD
Pethidine—Insomnia—Cyclosporine—psoriasis	0.000301	0.00123	CcSEcCtD
Pethidine—Loss of consciousness—Triamcinolone—psoriasis	0.0003	0.00123	CcSEcCtD
Pethidine—Shock—Prednisolone—psoriasis	0.000298	0.00122	CcSEcCtD
Pethidine—Somnolence—Cyclosporine—psoriasis	0.000296	0.00121	CcSEcCtD
Pethidine—Oedema—Hydrocortisone—psoriasis	0.000296	0.00121	CcSEcCtD
Pethidine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000296	0.00121	CcSEcCtD
Pethidine—Convulsion—Triamcinolone—psoriasis	0.000296	0.00121	CcSEcCtD
Pethidine—Tachycardia—Prednisolone—psoriasis	0.000296	0.00121	CcSEcCtD
Pethidine—Asthenia—Mycophenolic acid—psoriasis	0.000295	0.00121	CcSEcCtD
Pethidine—Hypertension—Triamcinolone—psoriasis	0.000295	0.00121	CcSEcCtD
Pethidine—Insomnia—Mycophenolate mofetil—psoriasis	0.000294	0.0012	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisolone—psoriasis	0.000293	0.0012	CcSEcCtD
Pethidine—Nausea—Hydroxyurea—psoriasis	0.000292	0.00119	CcSEcCtD
Pethidine—Pruritus—Mycophenolic acid—psoriasis	0.000291	0.00119	CcSEcCtD
Pethidine—Shock—Hydrocortisone—psoriasis	0.000291	0.00119	CcSEcCtD
Pethidine—Decreased appetite—Cyclosporine—psoriasis	0.00029	0.00118	CcSEcCtD
Pethidine—Tachycardia—Hydrocortisone—psoriasis	0.000289	0.00118	CcSEcCtD
Pethidine—Somnolence—Mycophenolate mofetil—psoriasis	0.000289	0.00118	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—psoriasis	0.000289	0.00118	CcSEcCtD
Pethidine—Flushing—Prednisone—psoriasis	0.000288	0.00118	CcSEcCtD
Pethidine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000286	0.00117	CcSEcCtD
Pethidine—Constipation—Cyclosporine—psoriasis	0.000285	0.00116	CcSEcCtD
Pethidine—Dry mouth—Triamcinolone—psoriasis	0.000284	0.00116	CcSEcCtD
Pethidine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000282	0.00115	CcSEcCtD
Pethidine—Anorexia—Hydrocortisone—psoriasis	0.000282	0.00115	CcSEcCtD
Pethidine—Anaphylactic shock—Triamcinolone—psoriasis	0.000279	0.00114	CcSEcCtD
Pethidine—Oedema—Triamcinolone—psoriasis	0.000279	0.00114	CcSEcCtD
Pethidine—Vertigo—Betamethasone—psoriasis	0.000278	0.00114	CcSEcCtD
Pethidine—Vertigo—Dexamethasone—psoriasis	0.000278	0.00114	CcSEcCtD
Pethidine—Syncope—Betamethasone—psoriasis	0.000278	0.00114	CcSEcCtD
Pethidine—Syncope—Dexamethasone—psoriasis	0.000278	0.00114	CcSEcCtD
Pethidine—Constipation—Mycophenolate mofetil—psoriasis	0.000278	0.00114	CcSEcCtD
Pethidine—Sweating—Methotrexate—psoriasis	0.000277	0.00113	CcSEcCtD
Pethidine—Hypotension—Hydrocortisone—psoriasis	0.000277	0.00113	CcSEcCtD
Pethidine—Feeling abnormal—Cyclosporine—psoriasis	0.000275	0.00112	CcSEcCtD
Pethidine—Shock—Triamcinolone—psoriasis	0.000274	0.00112	CcSEcCtD
Pethidine—Insomnia—Prednisolone—psoriasis	0.000274	0.00112	CcSEcCtD
Pethidine—Loss of consciousness—Betamethasone—psoriasis	0.000272	0.00111	CcSEcCtD
Pethidine—Loss of consciousness—Dexamethasone—psoriasis	0.000272	0.00111	CcSEcCtD
Pethidine—Dizziness—Mycophenolic acid—psoriasis	0.000272	0.00111	CcSEcCtD
Pethidine—Tachycardia—Triamcinolone—psoriasis	0.000272	0.00111	CcSEcCtD
Pethidine—Erythema—Prednisone—psoriasis	0.00027	0.0011	CcSEcCtD
Pethidine—Hyperhidrosis—Triamcinolone—psoriasis	0.000269	0.0011	CcSEcCtD
Pethidine—Convulsion—Dexamethasone—psoriasis	0.000269	0.0011	CcSEcCtD
Pethidine—Convulsion—Betamethasone—psoriasis	0.000269	0.0011	CcSEcCtD
Pethidine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000268	0.00109	CcSEcCtD
Pethidine—Insomnia—Hydrocortisone—psoriasis	0.000268	0.00109	CcSEcCtD
Pethidine—Hypertension—Betamethasone—psoriasis	0.000268	0.00109	CcSEcCtD
Pethidine—Hypertension—Dexamethasone—psoriasis	0.000268	0.00109	CcSEcCtD
Pethidine—Urticaria—Cyclosporine—psoriasis	0.000265	0.00108	CcSEcCtD
Pethidine—Anxiety—Betamethasone—psoriasis	0.000263	0.00107	CcSEcCtD
Pethidine—Anxiety—Dexamethasone—psoriasis	0.000263	0.00107	CcSEcCtD
Pethidine—Vomiting—Mycophenolic acid—psoriasis	0.000262	0.00107	CcSEcCtD
Pethidine—Rash—Mycophenolic acid—psoriasis	0.00026	0.00106	CcSEcCtD
Pethidine—Dermatitis—Mycophenolic acid—psoriasis	0.000259	0.00106	CcSEcCtD
Pethidine—Urticaria—Mycophenolate mofetil—psoriasis	0.000258	0.00106	CcSEcCtD
Pethidine—Headache—Mycophenolic acid—psoriasis	0.000258	0.00105	CcSEcCtD
Pethidine—Decreased appetite—Hydrocortisone—psoriasis	0.000257	0.00105	CcSEcCtD
Pethidine—Oedema—Betamethasone—psoriasis	0.000253	0.00103	CcSEcCtD
Pethidine—Anaphylactic shock—Dexamethasone—psoriasis	0.000253	0.00103	CcSEcCtD
Pethidine—Anaphylactic shock—Betamethasone—psoriasis	0.000253	0.00103	CcSEcCtD
Pethidine—Oedema—Dexamethasone—psoriasis	0.000253	0.00103	CcSEcCtD
Pethidine—Insomnia—Triamcinolone—psoriasis	0.000252	0.00103	CcSEcCtD
Pethidine—Feeling abnormal—Prednisolone—psoriasis	0.00025	0.00102	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—psoriasis	0.00025	0.00102	CcSEcCtD
Pethidine—Shock—Betamethasone—psoriasis	0.000249	0.00102	CcSEcCtD
Pethidine—Shock—Dexamethasone—psoriasis	0.000249	0.00102	CcSEcCtD
Pethidine—Agitation—Prednisone—psoriasis	0.000248	0.00101	CcSEcCtD
Pethidine—Tachycardia—Betamethasone—psoriasis	0.000247	0.00101	CcSEcCtD
Pethidine—Tachycardia—Dexamethasone—psoriasis	0.000247	0.00101	CcSEcCtD
Pethidine—Hypersensitivity—Cyclosporine—psoriasis	0.000245	0.001	CcSEcCtD
Pethidine—Nausea—Mycophenolic acid—psoriasis	0.000245	0.001	CcSEcCtD
Pethidine—Hyperhidrosis—Betamethasone—psoriasis	0.000245	0.001	CcSEcCtD
Pethidine—Hyperhidrosis—Dexamethasone—psoriasis	0.000245	0.001	CcSEcCtD
Pethidine—Feeling abnormal—Hydrocortisone—psoriasis	0.000244	0.000997	CcSEcCtD
Pethidine—Vertigo—Prednisone—psoriasis	0.000242	0.000991	CcSEcCtD
Pethidine—Syncope—Prednisone—psoriasis	0.000242	0.000989	CcSEcCtD
Pethidine—Anorexia—Dexamethasone—psoriasis	0.000241	0.000986	CcSEcCtD
Pethidine—Anorexia—Betamethasone—psoriasis	0.000241	0.000986	CcSEcCtD
Pethidine—Urticaria—Prednisolone—psoriasis	0.000241	0.000984	CcSEcCtD
Pethidine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000239	0.000979	CcSEcCtD
Pethidine—Asthenia—Cyclosporine—psoriasis	0.000239	0.000977	CcSEcCtD
Pethidine—Loss of consciousness—Prednisone—psoriasis	0.000237	0.00097	CcSEcCtD
Pethidine—Hypotension—Betamethasone—psoriasis	0.000236	0.000966	CcSEcCtD
Pethidine—Hypotension—Dexamethasone—psoriasis	0.000236	0.000966	CcSEcCtD
Pethidine—Pruritus—Cyclosporine—psoriasis	0.000236	0.000963	CcSEcCtD
Pethidine—Urticaria—Hydrocortisone—psoriasis	0.000235	0.000961	CcSEcCtD
Pethidine—Convulsion—Prednisone—psoriasis	0.000234	0.000956	CcSEcCtD
Pethidine—Asthenia—Mycophenolate mofetil—psoriasis	0.000233	0.000953	CcSEcCtD
Pethidine—Hypertension—Prednisone—psoriasis	0.000233	0.000953	CcSEcCtD
Pethidine—Pruritus—Mycophenolate mofetil—psoriasis	0.00023	0.00094	CcSEcCtD
Pethidine—Feeling abnormal—Triamcinolone—psoriasis	0.00023	0.000939	CcSEcCtD
Pethidine—Anxiety—Prednisone—psoriasis	0.000229	0.000936	CcSEcCtD
Pethidine—Insomnia—Betamethasone—psoriasis	0.000229	0.000935	CcSEcCtD
Pethidine—Insomnia—Dexamethasone—psoriasis	0.000229	0.000935	CcSEcCtD
Pethidine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000228	0.00617	CbGpPWpGaD
Pethidine—Erythema—Methotrexate—psoriasis	0.000226	0.000922	CcSEcCtD
Pethidine—Hypersensitivity—Prednisolone—psoriasis	0.000223	0.000913	CcSEcCtD
Pethidine—Urticaria—Triamcinolone—psoriasis	0.000221	0.000905	CcSEcCtD
Pethidine—OPRM1—IL4-mediated signaling events—IL10—psoriasis	0.000221	0.00597	CbGpPWpGaD
Pethidine—Dizziness—Cyclosporine—psoriasis	0.00022	0.0009	CcSEcCtD
Pethidine—Oedema—Prednisone—psoriasis	0.00022	0.0009	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisone—psoriasis	0.00022	0.0009	CcSEcCtD
Pethidine—Decreased appetite—Betamethasone—psoriasis	0.00022	0.000899	CcSEcCtD
Pethidine—Decreased appetite—Dexamethasone—psoriasis	0.00022	0.000899	CcSEcCtD
Pethidine—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000219	0.00592	CbGpPWpGaD
Pethidine—Hypersensitivity—Hydrocortisone—psoriasis	0.000218	0.000892	CcSEcCtD
Pethidine—Shock—Prednisone—psoriasis	0.000217	0.000886	CcSEcCtD
Pethidine—OPRK1—Peptide ligand-binding receptors—CCL20—psoriasis	0.000216	0.00584	CbGpPWpGaD
Pethidine—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000216	0.00584	CbGpPWpGaD
Pethidine—Tachycardia—Prednisone—psoriasis	0.000215	0.000879	CcSEcCtD
Pethidine—Dizziness—Mycophenolate mofetil—psoriasis	0.000215	0.000878	CcSEcCtD
Pethidine—OPRM1—IL4-mediated signaling events—IL4—psoriasis	0.000215	0.00581	CbGpPWpGaD
Pethidine—Hyperhidrosis—Prednisone—psoriasis	0.000213	0.00087	CcSEcCtD
Pethidine—Asthenia—Hydrocortisone—psoriasis	0.000212	0.000868	CcSEcCtD
Pethidine—OPRK1—GPCR ligand binding—HCAR2—psoriasis	0.000212	0.00575	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IL4—psoriasis	0.000212	0.00574	CbGpPWpGaD
Pethidine—Vomiting—Cyclosporine—psoriasis	0.000212	0.000866	CcSEcCtD
Pethidine—Rash—Cyclosporine—psoriasis	0.00021	0.000859	CcSEcCtD
Pethidine—Anorexia—Prednisone—psoriasis	0.00021	0.000858	CcSEcCtD
Pethidine—Dermatitis—Cyclosporine—psoriasis	0.00021	0.000858	CcSEcCtD
Pethidine—Pruritus—Hydrocortisone—psoriasis	0.000209	0.000856	CcSEcCtD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL13—psoriasis	0.000209	0.00565	CbGpPWpGaD
Pethidine—Headache—Cyclosporine—psoriasis	0.000209	0.000853	CcSEcCtD
Pethidine—Feeling abnormal—Dexamethasone—psoriasis	0.000208	0.000852	CcSEcCtD
Pethidine—Feeling abnormal—Betamethasone—psoriasis	0.000208	0.000852	CcSEcCtD
Pethidine—Vomiting—Mycophenolate mofetil—psoriasis	0.000207	0.000845	CcSEcCtD
Pethidine—Hypersensitivity—Triamcinolone—psoriasis	0.000205	0.00084	CcSEcCtD
Pethidine—Rash—Mycophenolate mofetil—psoriasis	0.000205	0.000838	CcSEcCtD
Pethidine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000205	0.000837	CcSEcCtD
Pethidine—SLC6A2—NRF2 pathway—TGFA—psoriasis	0.000204	0.00552	CbGpPWpGaD
Pethidine—Headache—Mycophenolate mofetil—psoriasis	0.000204	0.000832	CcSEcCtD
Pethidine—Vertigo—Methotrexate—psoriasis	0.000203	0.000828	CcSEcCtD
Pethidine—Urticaria—Betamethasone—psoriasis	0.000201	0.000821	CcSEcCtD
Pethidine—Urticaria—Dexamethasone—psoriasis	0.000201	0.000821	CcSEcCtD
Pethidine—Dizziness—Prednisolone—psoriasis	0.0002	0.000819	CcSEcCtD
Pethidine—Asthenia—Triamcinolone—psoriasis	0.0002	0.000818	CcSEcCtD
Pethidine—Insomnia—Prednisone—psoriasis	0.000199	0.000814	CcSEcCtD
Pethidine—Nausea—Cyclosporine—psoriasis	0.000198	0.000809	CcSEcCtD
Pethidine—Pruritus—Triamcinolone—psoriasis	0.000197	0.000806	CcSEcCtD
Pethidine—Dizziness—Hydrocortisone—psoriasis	0.000196	0.0008	CcSEcCtD
Pethidine—Convulsion—Methotrexate—psoriasis	0.000195	0.000799	CcSEcCtD
Pethidine—Nausea—Mycophenolate mofetil—psoriasis	0.000193	0.000789	CcSEcCtD
Pethidine—Decreased appetite—Prednisone—psoriasis	0.000191	0.000783	CcSEcCtD
Pethidine—Rash—Prednisolone—psoriasis	0.000191	0.000781	CcSEcCtD
Pethidine—Dermatitis—Prednisolone—psoriasis	0.000191	0.000781	CcSEcCtD
Pethidine—Headache—Prednisolone—psoriasis	0.00019	0.000776	CcSEcCtD
Pethidine—Constipation—Prednisone—psoriasis	0.000188	0.00077	CcSEcCtD
Pethidine—Vomiting—Hydrocortisone—psoriasis	0.000188	0.000769	CcSEcCtD
Pethidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000187	0.00507	CbGpPWpGaD
Pethidine—Rash—Hydrocortisone—psoriasis	0.000187	0.000763	CcSEcCtD
Pethidine—Dermatitis—Hydrocortisone—psoriasis	0.000186	0.000762	CcSEcCtD
Pethidine—Confusional state—Methotrexate—psoriasis	0.000186	0.000759	CcSEcCtD
Pethidine—Headache—Hydrocortisone—psoriasis	0.000185	0.000758	CcSEcCtD
Pethidine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000185	0.005	CbGpPWpGaD
Pethidine—Dizziness—Triamcinolone—psoriasis	0.000184	0.000754	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—psoriasis	0.000184	0.000753	CcSEcCtD
Pethidine—OPRM1—Peptide ligand-binding receptors—CCL20—psoriasis	0.000182	0.00494	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CCL20—psoriasis	0.000182	0.00493	CbGpPWpGaD
Pethidine—Feeling abnormal—Prednisone—psoriasis	0.000182	0.000742	CcSEcCtD
Pethidine—Asthenia—Betamethasone—psoriasis	0.000181	0.000742	CcSEcCtD
Pethidine—Asthenia—Dexamethasone—psoriasis	0.000181	0.000742	CcSEcCtD
Pethidine—SLC6A3—NRF2 pathway—TGFA—psoriasis	0.000181	0.00489	CbGpPWpGaD
Pethidine—Nausea—Prednisolone—psoriasis	0.00018	0.000736	CcSEcCtD
Pethidine—OPRM1—GPCR ligand binding—HCAR2—psoriasis	0.000179	0.00486	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—LEP—psoriasis	0.000179	0.00485	CbGpPWpGaD
Pethidine—Pruritus—Betamethasone—psoriasis	0.000179	0.000732	CcSEcCtD
Pethidine—Pruritus—Dexamethasone—psoriasis	0.000179	0.000732	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—psoriasis	0.000178	0.000727	CcSEcCtD
Pethidine—Vomiting—Triamcinolone—psoriasis	0.000177	0.000725	CcSEcCtD
Pethidine—SLC6A4—Monoamine Transport—TNF—psoriasis	0.000177	0.00478	CbGpPWpGaD
Pethidine—Nausea—Hydrocortisone—psoriasis	0.000176	0.000719	CcSEcCtD
Pethidine—Rash—Triamcinolone—psoriasis	0.000176	0.000718	CcSEcCtD
Pethidine—Dermatitis—Triamcinolone—psoriasis	0.000176	0.000718	CcSEcCtD
Pethidine—Anorexia—Methotrexate—psoriasis	0.000175	0.000717	CcSEcCtD
Pethidine—Urticaria—Prednisone—psoriasis	0.000175	0.000715	CcSEcCtD
Pethidine—Headache—Triamcinolone—psoriasis	0.000175	0.000714	CcSEcCtD
Pethidine—GRIN1—SIDS Susceptibility Pathways—IL10—psoriasis	0.000174	0.00472	CbGpPWpGaD
Pethidine—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000174	0.0047	CbGpPWpGaD
Pethidine—Hypotension—Methotrexate—psoriasis	0.000172	0.000703	CcSEcCtD
Pethidine—GRIN2C—Alzheimers Disease—TNF—psoriasis	0.000172	0.00465	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—ICAM1—psoriasis	0.000168	0.00456	CbGpPWpGaD
Pethidine—Dizziness—Dexamethasone—psoriasis	0.000167	0.000684	CcSEcCtD
Pethidine—Dizziness—Betamethasone—psoriasis	0.000167	0.000684	CcSEcCtD
Pethidine—GRIN1—Spinal Cord Injury—NOS2—psoriasis	0.000167	0.00452	CbGpPWpGaD
Pethidine—Insomnia—Methotrexate—psoriasis	0.000167	0.000681	CcSEcCtD
Pethidine—Nausea—Triamcinolone—psoriasis	0.000166	0.000677	CcSEcCtD
Pethidine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000165	0.00447	CbGpPWpGaD
Pethidine—Somnolence—Methotrexate—psoriasis	0.000164	0.000669	CcSEcCtD
Pethidine—SLC6A3—Dopaminergic Neurogenesis—STAT3—psoriasis	0.000164	0.00443	CbGpPWpGaD
Pethidine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000163	0.00441	CbGpPWpGaD
Pethidine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000163	0.0044	CbGpPWpGaD
Pethidine—Hypersensitivity—Prednisone—psoriasis	0.000162	0.000663	CcSEcCtD
Pethidine—OPRM1—TCR Signaling Pathway—CD8A—psoriasis	0.000162	0.00438	CbGpPWpGaD
Pethidine—Vomiting—Betamethasone—psoriasis	0.000161	0.000657	CcSEcCtD
Pethidine—Vomiting—Dexamethasone—psoriasis	0.000161	0.000657	CcSEcCtD
Pethidine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.00016	0.00434	CbGpPWpGaD
Pethidine—Decreased appetite—Methotrexate—psoriasis	0.00016	0.000654	CcSEcCtD
Pethidine—GRIN2D—Alzheimers Disease—TNF—psoriasis	0.000159	0.00432	CbGpPWpGaD
Pethidine—Rash—Betamethasone—psoriasis	0.000159	0.000652	CcSEcCtD
Pethidine—Rash—Dexamethasone—psoriasis	0.000159	0.000652	CcSEcCtD
Pethidine—Dermatitis—Betamethasone—psoriasis	0.000159	0.000651	CcSEcCtD
Pethidine—Dermatitis—Dexamethasone—psoriasis	0.000159	0.000651	CcSEcCtD
Pethidine—Headache—Dexamethasone—psoriasis	0.000158	0.000648	CcSEcCtD
Pethidine—Headache—Betamethasone—psoriasis	0.000158	0.000648	CcSEcCtD
Pethidine—Asthenia—Prednisone—psoriasis	0.000158	0.000646	CcSEcCtD
Pethidine—Pruritus—Prednisone—psoriasis	0.000156	0.000637	CcSEcCtD
Pethidine—OPRM1—G alpha (i) signalling events—CCL20—psoriasis	0.000154	0.00417	CbGpPWpGaD
Pethidine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000152	0.00412	CbGpPWpGaD
Pethidine—SLC6A2—Monoamine Transport—TNF—psoriasis	0.000152	0.00411	CbGpPWpGaD
Pethidine—Feeling abnormal—Methotrexate—psoriasis	0.000152	0.00062	CcSEcCtD
Pethidine—GRIN2C—Alzheimers Disease—TP53—psoriasis	0.000151	0.0041	CbGpPWpGaD
Pethidine—Nausea—Betamethasone—psoriasis	0.00015	0.000614	CcSEcCtD
Pethidine—Nausea—Dexamethasone—psoriasis	0.00015	0.000614	CcSEcCtD
Pethidine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.00015	0.00406	CbGpPWpGaD
Pethidine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000147	0.00399	CbGpPWpGaD
Pethidine—Urticaria—Methotrexate—psoriasis	0.000146	0.000598	CcSEcCtD
Pethidine—Dizziness—Prednisone—psoriasis	0.000146	0.000595	CcSEcCtD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000145	0.00392	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—NFKBIA—psoriasis	0.000142	0.00386	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SERPINB8—psoriasis	0.000142	0.00384	CbGpPWpGaD
Pethidine—GRIN2D—Alzheimers Disease—TP53—psoriasis	0.000141	0.00381	CbGpPWpGaD
Pethidine—Vomiting—Prednisone—psoriasis	0.00014	0.000573	CcSEcCtD
Pethidine—Rash—Prednisone—psoriasis	0.000139	0.000568	CcSEcCtD
Pethidine—GRIN2B—BDNF signaling pathway—NFKBIA—psoriasis	0.000139	0.00376	CbGpPWpGaD
Pethidine—Dermatitis—Prednisone—psoriasis	0.000139	0.000567	CcSEcCtD
Pethidine—Headache—Prednisone—psoriasis	0.000138	0.000564	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—psoriasis	0.000136	0.000554	CcSEcCtD
Pethidine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	0.000135	0.00366	CbGpPWpGaD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000135	0.00365	CbGpPWpGaD
Pethidine—SLC6A3—Monoamine Transport—TNF—psoriasis	0.000134	0.00364	CbGpPWpGaD
Pethidine—Asthenia—Methotrexate—psoriasis	0.000132	0.00054	CcSEcCtD
Pethidine—GRIN2A—Alzheimers Disease—TNF—psoriasis	0.000131	0.00355	CbGpPWpGaD
Pethidine—Nausea—Prednisone—psoriasis	0.000131	0.000535	CcSEcCtD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL10—psoriasis	0.000131	0.00354	CbGpPWpGaD
Pethidine—Pruritus—Methotrexate—psoriasis	0.00013	0.000532	CcSEcCtD
Pethidine—GRIN1—Spinal Cord Injury—IFNG—psoriasis	0.000128	0.00347	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—NFKBIA—psoriasis	0.000126	0.0034	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000122	0.00331	CbGpPWpGaD
Pethidine—Dizziness—Methotrexate—psoriasis	0.000122	0.000498	CcSEcCtD
Pethidine—OPRK1—GPCR downstream signaling—HCAR2—psoriasis	0.00012	0.00325	CbGpPWpGaD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000119	0.00323	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—CARM1—psoriasis	0.000119	0.00323	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—CXCL8—psoriasis	0.000119	0.00322	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—CAT—psoriasis	0.000119	0.00322	CbGpPWpGaD
Pethidine—Vomiting—Methotrexate—psoriasis	0.000117	0.000478	CcSEcCtD
Pethidine—GRIN2B—Developmental Biology—CARM1—psoriasis	0.000116	0.00315	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—CRP—psoriasis	0.000116	0.00314	CbGpPWpGaD
Pethidine—Rash—Methotrexate—psoriasis	0.000116	0.000474	CcSEcCtD
Pethidine—GRIN1—EPH-Ephrin signaling—VEGFA—psoriasis	0.000116	0.00314	CbGpPWpGaD
Pethidine—Dermatitis—Methotrexate—psoriasis	0.000116	0.000474	CcSEcCtD
Pethidine—GRIN2A—Alzheimers Disease—TP53—psoriasis	0.000115	0.00313	CbGpPWpGaD
Pethidine—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	0.000115	0.00313	CbGpPWpGaD
Pethidine—Headache—Methotrexate—psoriasis	0.000115	0.000471	CcSEcCtD
Pethidine—GRIN1—Alzheimers Disease—TNF—psoriasis	0.000114	0.00309	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—APOE—psoriasis	0.000114	0.00308	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—VEGFA—psoriasis	0.000113	0.00306	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TNF—psoriasis	0.000111	0.00302	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CCL20—psoriasis	0.00011	0.00298	CbGpPWpGaD
Pethidine—Nausea—Methotrexate—psoriasis	0.000109	0.000447	CcSEcCtD
Pethidine—ALB—Folate Metabolism—IL4—psoriasis	0.000109	0.00296	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HCAR2—psoriasis	0.000109	0.00295	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	0.000107	0.00289	CbGpPWpGaD
Pethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000106	0.00287	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—HCAR2—psoriasis	0.000101	0.00274	CbGpPWpGaD
Pethidine—GRIN1—Alzheimers Disease—TP53—psoriasis	0.000101	0.00273	CbGpPWpGaD
Pethidine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	9.94e-05	0.00269	CbGpPWpGaD
Pethidine—GRIN2B—Alzheimers Disease—TP53—psoriasis	9.82e-05	0.00266	CbGpPWpGaD
Pethidine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	9.8e-05	0.00265	CbGpPWpGaD
Pethidine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	9.53e-05	0.00258	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—CXCL8—psoriasis	9.52e-05	0.00258	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—CAT—psoriasis	9.45e-05	0.00256	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—CRP—psoriasis	9.45e-05	0.00256	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—JUN—psoriasis	9.44e-05	0.00256	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CCL20—psoriasis	9.31e-05	0.00252	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—CD4—psoriasis	9.3e-05	0.00252	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HCAR2—psoriasis	9.2e-05	0.00249	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—JUN—psoriasis	9.2e-05	0.00249	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—NFKB1—psoriasis	9.09e-05	0.00246	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—NFKB1—psoriasis	8.86e-05	0.0024	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—JUN—psoriasis	8.85e-05	0.0024	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—LEP—psoriasis	8.77e-05	0.00238	CbGpPWpGaD
Pethidine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	8.76e-05	0.00237	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—ICAM1—psoriasis	8.68e-05	0.00235	CbGpPWpGaD
Pethidine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	8.57e-05	0.00232	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—NFKB1—psoriasis	8.52e-05	0.00231	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—JUN—psoriasis	8.32e-05	0.00225	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TNF—psoriasis	8.29e-05	0.00224	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—NOS2—psoriasis	8.18e-05	0.00221	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—STAT3—psoriasis	8.16e-05	0.00221	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	8.12e-05	0.0022	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—NFKB1—psoriasis	8.01e-05	0.00217	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—STAT3—psoriasis	7.96e-05	0.00216	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—VEGFA—psoriasis	7.73e-05	0.00209	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—PPARG—psoriasis	7.64e-05	0.00207	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—CRP—psoriasis	7.5e-05	0.00203	CbGpPWpGaD
Pethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.39e-05	0.002	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—TP53—psoriasis	7.31e-05	0.00198	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	7.14e-05	0.00193	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	6.9e-05	0.00187	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	6.85e-05	0.00185	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—CP—psoriasis	6.77e-05	0.00183	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	6.76e-05	0.00183	CbGpPWpGaD
Pethidine—GRIN1—Spinal Cord Injury—IL6—psoriasis	6.69e-05	0.00181	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	6.64e-05	0.0018	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—TNF—psoriasis	6.63e-05	0.00179	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IFNG—psoriasis	6.61e-05	0.00179	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	6.53e-05	0.00177	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HCAR2—psoriasis	6.43e-05	0.00174	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	6.39e-05	0.00173	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CCL20—psoriasis	6.23e-05	0.00169	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—TYK2—psoriasis	6.09e-05	0.00165	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—CP—psoriasis	6.06e-05	0.00164	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—TYK2—psoriasis	5.94e-05	0.00161	CbGpPWpGaD
Pethidine—OPRK1—Peptide ligand-binding receptors—CXCL8—psoriasis	5.83e-05	0.00158	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	5.8e-05	0.00157	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—CARM1—psoriasis	5.79e-05	0.00157	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—LEP—psoriasis	5.7e-05	0.00154	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CCL20—psoriasis	5.66e-05	0.00153	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TAGAP—psoriasis	5.58e-05	0.00151	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—LEP—psoriasis	5.55e-05	0.0015	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—NFKB1—psoriasis	5.5e-05	0.00149	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HCAR2—psoriasis	5.44e-05	0.00147	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—JUN—psoriasis	5.42e-05	0.00147	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—IL6—psoriasis	5.35e-05	0.00145	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CCL20—psoriasis	5.26e-05	0.00143	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—TNF—psoriasis	5.26e-05	0.00142	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IFNG—psoriasis	5.25e-05	0.00142	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—IL6—psoriasis	5.03e-05	0.00136	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	4.97e-05	0.00135	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—PPARG—psoriasis	4.96e-05	0.00134	CbGpPWpGaD
Pethidine—OPRM1—Peptide ligand-binding receptors—CXCL8—psoriasis	4.92e-05	0.00133	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—CXCL8—psoriasis	4.91e-05	0.00133	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—PPARG—psoriasis	4.84e-05	0.00131	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CCL20—psoriasis	4.78e-05	0.00129	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TAGAP—psoriasis	4.71e-05	0.00128	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NDUFA5—psoriasis	4.4e-05	0.00119	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	4.37e-05	0.00118	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TYK2—psoriasis	4.35e-05	0.00118	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—VEGFA—psoriasis	4.31e-05	0.00117	CbGpPWpGaD
Pethidine—ALB—Platelet degranulation—VEGFA—psoriasis	4.28e-05	0.00116	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TNF—psoriasis	4.28e-05	0.00116	CbGpPWpGaD
Pethidine—ALB—Vitamin B12 Metabolism—IL6—psoriasis	4.24e-05	0.00115	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TYK2—psoriasis	4.24e-05	0.00115	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—VEGFA—psoriasis	4.2e-05	0.00114	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—CXCL8—psoriasis	4.15e-05	0.00112	CbGpPWpGaD
Pethidine—ALB—Hemostasis—ITGAL—psoriasis	4.12e-05	0.00111	CbGpPWpGaD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	4.07e-05	0.0011	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	4.01e-05	0.00109	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.91e-05	0.00106	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—psoriasis	3.77e-05	0.00102	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CYP2S1—psoriasis	3.74e-05	0.00101	CbGpPWpGaD
Pethidine—ALB—Metabolism—NDUFA5—psoriasis	3.7e-05	0.001	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	3.58e-05	0.000969	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.45e-05	0.000935	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—IL6—psoriasis	3.45e-05	0.000934	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—CP—psoriasis	3.44e-05	0.000932	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—TNF—psoriasis	3.4e-05	0.00092	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—NFKB1—psoriasis	3.39e-05	0.000918	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL20—psoriasis	3.34e-05	0.000905	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NDUFA5—psoriasis	3.32e-05	0.0009	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—NFKB1—psoriasis	3.3e-05	0.000895	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.3e-05	0.000894	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	3.28e-05	0.000889	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	3.28e-05	0.000887	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYP2S1—psoriasis	3.15e-05	0.000852	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.1e-05	0.000839	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—VEGFA—psoriasis	3.08e-05	0.000833	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NDUFA5—psoriasis	3.06e-05	0.000828	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—STAT3—psoriasis	3.05e-05	0.000825	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—VEGFA—psoriasis	3e-05	0.000812	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—IL6—psoriasis	2.98e-05	0.000807	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CXCL8—psoriasis	2.98e-05	0.000806	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—STAT3—psoriasis	2.97e-05	0.000804	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—IL6—psoriasis	2.91e-05	0.000787	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYP2S1—psoriasis	2.83e-05	0.000765	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL20—psoriasis	2.82e-05	0.000765	CbGpPWpGaD
Pethidine—ALB—Selenium Micronutrient Network—IL6—psoriasis	2.74e-05	0.000742	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—TNF—psoriasis	2.64e-05	0.000714	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.6e-05	0.000704	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—TNF—psoriasis	2.57e-05	0.000696	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CXCL8—psoriasis	2.51e-05	0.000681	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—IL6—psoriasis	2.13e-05	0.000576	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—IL6—psoriasis	2.07e-05	0.000562	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NDUFA5—psoriasis	2e-05	0.000541	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.9e-05	0.000514	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SOCS1—psoriasis	1.84e-05	0.000498	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CARM1—psoriasis	1.83e-05	0.000495	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—TYK2—psoriasis	1.75e-05	0.000475	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.7e-05	0.00046	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NOS2—psoriasis	1.69e-05	0.000457	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—CXCL8—psoriasis	1.68e-05	0.000455	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.65e-05	0.000447	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SOCS1—psoriasis	1.55e-05	0.000421	CbGpPWpGaD
Pethidine—ALB—Metabolism—CARM1—psoriasis	1.54e-05	0.000416	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CXCL8—psoriasis	1.53e-05	0.000414	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—TYK2—psoriasis	1.48e-05	0.000401	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.48e-05	0.000401	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.44e-05	0.000389	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—CXCL8—psoriasis	1.42e-05	0.000385	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CARM1—psoriasis	1.38e-05	0.000374	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—LEP—psoriasis	1.36e-05	0.000368	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—APOE—psoriasis	1.36e-05	0.000368	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CXCL8—psoriasis	1.29e-05	0.00035	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.29e-05	0.000349	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CARM1—psoriasis	1.27e-05	0.000344	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NFKBIA—psoriasis	1.26e-05	0.000343	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—LEP—psoriasis	1.15e-05	0.000311	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—APOE—psoriasis	1.15e-05	0.000311	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CAT—psoriasis	1.12e-05	0.000304	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKBIA—psoriasis	1.07e-05	0.00029	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TYK2—psoriasis	1.04e-05	0.000281	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—psoriasis	9.78e-06	0.000265	CbGpPWpGaD
Pethidine—ALB—Metabolism—CAT—psoriasis	9.45e-06	0.000256	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CXCL8—psoriasis	9.02e-06	0.000244	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TYK2—psoriasis	8.76e-06	0.000237	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—APOE—psoriasis	8.73e-06	0.000236	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—psoriasis	8.58e-06	0.000232	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CAT—psoriasis	8.49e-06	0.00023	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—psoriasis	8.39e-06	0.000227	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CARM1—psoriasis	8.3e-06	0.000225	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NFKB1—psoriasis	8.07e-06	0.000219	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CAT—psoriasis	7.81e-06	0.000211	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CXCL8—psoriasis	7.62e-06	0.000206	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPARG—psoriasis	7.6e-06	0.000206	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—psoriasis	7.39e-06	0.0002	CbGpPWpGaD
Pethidine—ALB—Metabolism—APOE—psoriasis	7.35e-06	0.000199	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—psoriasis	7.33e-06	0.000198	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—psoriasis	7.25e-06	0.000196	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—psoriasis	7.25e-06	0.000196	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—psoriasis	7.09e-06	0.000192	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKB1—psoriasis	6.82e-06	0.000185	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—APOE—psoriasis	6.59e-06	0.000179	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPARG—psoriasis	6.4e-06	0.000173	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—psoriasis	6.19e-06	0.000168	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—psoriasis	6.13e-06	0.000166	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—APOE—psoriasis	6.07e-06	0.000164	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPARG—psoriasis	5.74e-06	0.000156	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—psoriasis	5.54e-06	0.00015	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPARG—psoriasis	5.28e-06	0.000143	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CAT—psoriasis	5.1e-06	0.000138	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—psoriasis	5.07e-06	0.000137	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—psoriasis	4.68e-06	0.000127	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—psoriasis	4.28e-06	0.000116	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—APOE—psoriasis	3.97e-06	0.000107	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPARG—psoriasis	3.45e-06	9.35e-05	CbGpPWpGaD
